BIOMAT Database Logo BIOMAT Database Logo

Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. 1994

H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.

To investigate the role of apoE in hepatic uptake of chylomicron remnants, we studied chylomicron metabolism in transgenic mice overexpressing apoE in the liver. Plasma clearance of injected 125I-labeled human chylomicrons was fivefold faster in transgenic mice than in controls. Immunohistochemistry demonstrated that apoE was specifically localized at the basolateral surface of hepatocytes from fasted transgenic mice. After injection of a large amount of chylomicrons, the density of the cell surface apoE was markedly reduced and vesicular staining was observed in the cytoplasm, suggesting that the cell surface apoE was used for hepatic endocytosis of chylomicrons and remnants. Polyacrylamide gel analysis of chylomicrons and remnants that had been reisolated from plasma and from liver membrane after the injection of chylomicrons showed the particles to be enriched with apoE mainly after their influx into the liver rather than during their residence in plasma. These results provide strong evidence for the secretion-recapture process of apoE, whereby chylomicron remnants enter the sinusoidal space, acquire apoE molecules, and subsequently are endocytosed. Data from experiments with very low density lipoprotein and LDL showed that this system is specific for chylomicron remnants.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D002914 Chylomicrons A class of lipoproteins that carry dietary CHOLESTEROL and TRIGLYCERIDES from the SMALL INTESTINE to the tissues. Their density (0.93-1.006 g/ml) is the same as that of VERY-LOW-DENSITY LIPOPROTEINS. Chylomicron
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses

Related Publications

H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Hepatic uptake of chylomicron remnants.
November 1997, Journal of lipid research,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Hepatic lipase treatment of chylomicron remnants increases exposure of apolipoprotein E.
March 1993, Journal of lipid research,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Hepatic clearance of chylomicron remnants in mice lacking apoprotein E.
November 1994, Biochimica et biophysica acta,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase.
January 2005, Journal of lipid research,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
The apoprotein B-independent hepatic uptake of chylomicron remnants.
May 1982, The Biochemical journal,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Effect of chylomicron remnants on apolipoprotein E synthesis in HepG2 cells.
January 1994, Metabolism: clinical and experimental,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids.
September 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Receptor-ligand interactions in the hepatic uptake of chylomicron remnants studied with genetically manipulated mice.
June 1996, Zeitschrift fur Gastroenterologie,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway.
May 1999, Journal of lipid research,
H Shimano, and Y Namba, and J Ohsuga, and M Kawamura, and K Yamamoto, and M Shimada, and T Gotoda, and K Harada, and Y Yazaki, and N Yamada
Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.
June 1986, Journal of lipid research,
Copied contents to your clipboard!